Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Cannasouth harvests 1st crop of medicinal research cannabis

Cannasouth has harvested its first crop of medicinal research cannabis from its purpose-built growing facility in Hamilton.

Cannasouth founders Mark Lucas and Nic Foreman have been growing industrial hemp varieties outdoors since 2002. However, this harvest is significant because of the high THC (tetrahydrocannabidiol) and CBD (cannabidiol) content of the plants, which are grown indoors under tight security.

Until now, Cannasouth has been conducting its research using raw high-grade THC-rich cannabis flower from the Netherlands - imported under a special licence from the Ministry of Health.

Cannasouth CEO Mark Lucas says the harvest is a significant milestone for the company in its efforts to develop quality cannabinoid formulations ready for human efficacy and drug delivery-controlled trials.

“Having our own growing facility at our back door means we have had complete control over the entire growing process to ensure we cultivate the highest-quality cannabis flowers for our R&D programmes. It also means we have access to plants when we need them so our research is not hampered by any delays.”

Cannasouth grows a range of cultivars at its Hamilton growing facility, which will be harvested at various times of the year depending on the demands of its research. Some of the cannabinoids needed may be more prevalent in plants later in the flowering stage.

Plants from Cannasouth’s first harvest were sown as seeds, before being planted as seedlings 10-12 weeks ago. They will now be hung and air-dried in a controlled environment.

“Once the plants are dried, they are packaged ready for delivery to our team of scientists at Innovation Park in Hamilton,” says Mr Lucas. “Their work then focuses on investigating methods of extraction, fractionation and purification, and studying cannabinoid degradation and stability profiles.

“What this means is that we will be able to develop the highest quality medicinal cannabis products, which are fit for purpose and have a long shelf life.

“Even though plants from our cultivation facility can’t be used to manufacture products until the Government’s medicinal cannabis access scheme comes into effect in 2020, this first harvest is an important step in our research and development efforts.”

CBD is a non-psychoactive compound in cannabis and has been associated with managing a range of medical conditions, including cancer-related symptoms and neurological disorders such as epilepsy and multiple sclerosis.

Mr. Lucas says CBD and THC are two of the more well-known compounds in medicinal cannabis that have been shown to relieve patients’ suffering from a wide range of conditions. However, there is significant potential to learn more about the properties of other rarer compounds and how they can assist in treating medical conditions.

“We know current medicinal cannabis medicines are helping a lot of people. This first harvest will give our research the fillip it needs to unlock more treatment options to further improve patient outcomes.”

© Scoop Media

Business Headlines | Sci-Tech Headlines


Energy Resources Aotearoa: Doubling Of Coal Use Shows Need For Local Natural Gas

New figures showing a near doubling of coal-fired electricity generation highlight New Zealand’s energy shortage and the need for natural gas as a lower carbon alternative, according to Energy Resources Aotearoa... More>>

E Tu: ‘Sense Of Mourning’ As Norske Skog Mill Set To Close

Workers at Norske Skog’s Tasman Mill now know they’ll be losing their jobs in little over a month’s time.
On Wednesday afternoon, workers were told the mill will be stopping production from the end of June... More>>

Stats NZ: Card Spending Sees Strong Growth In May

Seasonally adjusted card spending rose by $189 million (2.3 percent) between April 2021 and May 2021, Stats NZ said today.
Spending rose across all industries for the first time since New Zealand moved to level 1 in June 2020... More>>

Catalist: NZ’s New SME Stock Exchange, Gets Licence To Go Public

New Zealand has a new stock exchange – designed specifically for small and medium-sized businesses (SMEs) to raise up to $20 million a year from the public.
Called Catalist, the exchange has already been successfully working the private investment sector.... More>>

E-Commerce: Over 40% Of Those Engaged In The Bitcoin Community Are Millennials

Bitcoin has emerged to be a popular topic among millennials with digital currency increasingly being viewed as a potential source of creating wealth through investments. The interest in bitcoin by millennials signals the role this age group plays in the possible realization of the digital currency’s mass adoption... More>>

Stats NZ: New Zealand Is Getting Drier

While there is natural variation in precipitation due to seasons and cycles, New Zealand appears to be getting drier, Stats NZ said today... More>>